We are live on ! Find out more
ALDX icon

Aldeyra Therapeutics
ALDX

136 hedge funds and large institutions have $511M invested in Aldeyra Therapeutics in 2021 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 44 increasing their positions, 28 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 21

59% more call options, than puts

Call options by funds: $6.71M | Put options by funds: $4.21M

57% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 28

36% more capital invested

Capital invested by funds: $377M → $511M (+$134M)

26% more funds holding

Funds holding: 108 → 136 (+28)

11.46% more ownership

Funds ownership: 67.13% → 78.59% (+11%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

Holders
136
Holders Change
+28
Holders Change %
+25.93%
% of All Funds
2.37%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
49
Increased
44
Reduced
28
Closed
21
Calls
$6.71M
Puts
$4.21M
Net Calls
+$2.5M
Net Calls Change
+$3.29M

Top Buyers

1
BlackRock
BlackRock
New York
+$26.7M
2
PA
Perceptive Advisors
New York
+$14.4M
3
EAM
Eagle Asset Management
Florida
+$13.1M
4
WP
Woodline Partners
California
+$11.8M
5
Goldman Sachs
Goldman Sachs
New York
+$11.2M

Top Sellers

1
APM
Avidity Partners Management
Texas
-$13.3M
2
Citadel Advisors
Citadel Advisors
Florida
-$2.76M
3
ECM
ExodusPoint Capital Management
New York
-$1.86M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.85M
5
Millennium Management
Millennium Management
New York
-$1.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
EI
26
EAM Investors
California
$3.72M +$2.71M +225,348 +218%
LP
27
LMR Partners
United Kingdom
$3.09M +$3.01M +250,175 +1,103%
Dimensional Fund Advisors
28
Dimensional Fund Advisors
Texas
$3.08M -$41.5K -3,451 -1%
Deutsche Bank
29
Deutsche Bank
Germany
$2.95M -$473K -39,309 -13%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$2.52M +$2.1M +174,647 +369%
KFS
31
Kelly Financial Services
Massachusetts
$2.51M +$311K +25,897 +1,033%
Citigroup
32
Citigroup
New York
$2.4M -$237K -19,695 -9%
AAA
33
Affinity Asset Advisors
New York
$2.27M -$1.2M -100,000 -33%
SCM
34
Segantii Capital Management
Hong Kong
$2.27M +$2.4M +200,000 New
FMBTD
35
First Midwest Bank Trust Division
Illinois
$1.88M +$1.25M +103,897 +167%
PAI
36
Palo Alto Investors
California
$1.82M – – –
SFM
37
Sphera Funds Management
Israel
$1.7M +$1.8M +150,000 New
WC
38
Woodstock Corp
Massachusetts
$1.68M – – –
MIM
39
Monashee Investment Management
Massachusetts
$1.66M +$1.76M +146,584 New
First Trust Advisors
40
First Trust Advisors
Illinois
$1.66M +$315K +26,205 +22%
WMSA
41
Weiss Multi-Strategy Advisers
New York
$1.6M -$130K -10,779 -7%
Wells Fargo
42
Wells Fargo
California
$1.59M +$795K +66,152 +89%
EGI
43
EAM Global Investors
California
$1.59M +$1.69M +140,198 New
CS
44
Candriam SCA
Luxembourg
$1.59M +$1.68M +140,000 New
Rafferty Asset Management
45
Rafferty Asset Management
New York
$1.51M -$354K -29,427 -18%
PAM
46
Premier Asset Management
Illinois
$1.46M +$867K +72,074 +128%
Charles Schwab
47
Charles Schwab
California
$1.42M +$1.29M +106,972 +590%
CSS
48
Cubist Systematic Strategies
Connecticut
$1.37M +$454K +37,732 +45%
PPA
49
Parametric Portfolio Associates
Washington
$1.35M +$1.11M +92,171 +344%
Susquehanna International Group
50
Susquehanna International Group
Pennsylvania
$1.32M -$1.85M -154,268 -57%
1
2
3 4 5

ALDX Hedge Fund Activity: Q2 2021 in Review

136 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Aldeyra Therapeutics (ALDX) for Q2 2021, worth a combined $511M — up 36% from $377M a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new ALDX positions and 21 closed out — a net gain of 28 holders — while 44 added to existing stakes and 28 trimmed.

The largest buyer was BlackRock, adding an estimated $26.7M. The largest seller was Avidity Partners Management, cutting an estimated $13.3M.

  • 136 institutional investors held Aldeyra Therapeutics (ALDX) as of Q2 2021, up from 108 in Q1 2021.
  • Funds reported $511M of Aldeyra Therapeutics stock for Q2 2021, up 36% quarter-over-quarter.
  • 49 funds opened new Aldeyra Therapeutics positions in Q2 2021 and 21 closed out, a net change of +28 holders.
  • The largest Aldeyra Therapeutics buyer in Q2 2021 was BlackRock, an estimated $26.7M added.
  • The largest Aldeyra Therapeutics seller in Q2 2021 was Avidity Partners Management, an estimated $13.3M sold.

Based on aggregated 13F filings for Q2 2021.